Literature DB >> 22130661

Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.

Yong Li1, Jiao Wu, Fei Song, Juan Tang, Shi-Jie Wang, Xiao-Ling Yu, Zhi-Nan Chen, Jian-Li Jiang.   

Abstract

Several lines of evidence suggest that HAb18G/CD147 interacts with the integrin variants α3β1 and α6β1. However, the mechanism of the interaction remains largely unknown. In this study, mammalian protein-protein interaction trap (MAPPIT), a mammalian two-hybrid method, was used to study the CD147-integrin β1 subunit interaction. CD147 in human hepatocellular carcinoma (HCC) cells was interfered with by small hairpin RNA. Nude mouse xenograft model and metastatic model of HCC were used to detect the role of CD147 in carcinogenesis and metastasis. We found that the extracellular membrane-proximal domain of HAb18G/CD147 (I-type domain) binds at the metal ion-dependent adhesion site in the βA domain of the integrin β1 subunit, and Asp(179) in the I-type domain of HAb18G/CD147 plays an important role in the interaction. The levels of the proteins that act downstream of integrin, including focal adhesion kinase (FAK) and phospho-FAK, were decreased, and the cytoskeletal structures of HCC cells were rearranged bearing the HAb18G/CD147 deletion. Simultaneously, the migration and invasion capacities, secretion of matrix metalloproteinases, colony formation rate in vitro, and tumor growth and metastatic potential in vivo were decreased. These results indicate that the interaction of HAb18G/CD147 extracellular I-type domain with the integrin β1 metal ion-dependent adhesion site motif activates the downstream FAK signaling pathway, subsequently enhancing the malignant properties of HCC cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130661      PMCID: PMC3281619          DOI: 10.1074/jbc.M111.277699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion.

Authors:  Neil O Carragher; Margaret C Frame
Journal:  Trends Cell Biol       Date:  2004-05       Impact factor: 20.808

2.  Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.

Authors:  Zhi-Nan Chen; Li Mi; Jing Xu; Fei Song; Qing Zhang; Zheng Zhang; Jin-Liang Xing; Hui-Jie Bian; Jian-Li Jiang; Xian-Hui Wang; Peng Shang; Ai-Rong Qian; Si-He Zhang; Ling Li; Yu Li; Qiang Feng; Xiao-Ling Yu; Yuan Feng; Xiang-Min Yang; Rong Tian; Zhen-Biao Wu; Nan Leng; Ting-Shu Mo; An-Ren Kuang; Tian-Zhi Tan; Yun-Chun Li; De-Rong Liang; Wu-Sheng Lu; Jia Miao; Guo-Hui Xu; Zhi-Hui Zhang; Ke-Jun Nan; Jun Han; Qing-Guang Liu; Hong-Xin Zhang; Ping Zhu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

3.  A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.

Authors:  Jing Xu; Zhong-Yang Shen; Xin-Guo Chen; Qing Zhang; Hui-Jie Bian; Ping Zhu; Hui-Yun Xu; Fei Song; Xiang-Min Yang; Li Mi; Qing-Chuan Zhao; Rong Tian; Qiang Feng; Si-He Zhang; Yu Li; Jian-Li Jiang; Ling Li; Xiao-Ling Yu; Zheng Zhang; Zhi-Nan Chen
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

4.  siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway.

Authors:  Hui-Yun Xu; Ai-Rong Qian; Peng Shang; Jing Xu; Ling-Min Kong; Hui-Jie Bian; Zhi-Nan Chen
Journal:  Cancer Lett       Date:  2006-07-03       Impact factor: 8.679

5.  Evidence for the formation of multimeric forms of the 5A11/HT7 antigen.

Authors:  J M Fadool; P J Linser
Journal:  Biochem Biophys Res Commun       Date:  1996-12-04       Impact factor: 3.575

6.  Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture.

Authors:  Kathryn D Curtin; Ian A Meinertzhagen; Robert J Wyman
Journal:  J Cell Sci       Date:  2005-05-31       Impact factor: 5.285

7.  HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.

Authors:  Jing Xu; Hui-Yun Xu; Qing Zhang; Fei Song; Jian-Li Jiang; Xiang-Min Yang; Li Mi; Ning Wen; Rong Tian; Li Wang; Hui Yao; Qiang Feng; Yang Zhang; Jin-Liang Xing; Ping Zhu; Zhi-Nan Chen
Journal:  Mol Cancer Res       Date:  2007-06       Impact factor: 5.852

8.  Identification of ligand binding sites on integrin alpha4beta1 through chemical cross-linking.

Authors:  L L Chen; R R Lobb; J H Cuervo; K c Lin; S P Adams; R B Pepinsky
Journal:  Biochemistry       Date:  1998-06-16       Impact factor: 3.162

9.  Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6.

Authors:  F Berditchevski; S Chang; J Bodorova; M E Hemler
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

Review 10.  The integrins.

Authors:  Yoshikazu Takada; Xiaojing Ye; Scott Simon
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  34 in total

1.  CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma.

Authors:  J Tang; Y-S Guo; Y Zhang; X-L Yu; L Li; W Huang; Y Li; B Chen; J-L Jiang; Z-N Chen
Journal:  Cell Death Differ       Date:  2012-05-18       Impact factor: 15.828

2.  The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma.

Authors:  Haoyuan Yin; Ying Shao; Xuan Chen
Journal:  Neurol Sci       Date:  2016-10-19       Impact factor: 3.307

3.  A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.

Authors:  Yuan Wang; Lin Yuan; Xiang-Min Yang; Ding Wei; Bin Wang; Xiu-Xuan Sun; Fei Feng; Gang Nan; Ye Wang; Zhi-Nan Chen; Huijie Bian
Journal:  Clin Exp Metastasis       Date:  2014-11-26       Impact factor: 5.150

4.  Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia.

Authors:  Xia Ke; Yanke Chen; Pei Wang; Jinliang Xing; Zhinan Chen
Journal:  Hepatol Int       Date:  2014-05-03       Impact factor: 6.047

5.  PTTG promotes invasion in human breast cancer cell line by upregulating EMMPRIN via FAK/Akt/mTOR signaling.

Authors:  Hui Gao; Feng Zhong; Jing Xie; Jianjun Peng; Zhiwu Han
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

6.  Basigin Associates with Integrin in Order to Regulate Perineurial Glia and Drosophila Nervous System Morphology.

Authors:  Amelia C Hunter; Lindsay M Petley-Ragan; Mriga Das; Vanessa J Auld
Journal:  J Neurosci       Date:  2020-04-07       Impact factor: 6.167

7.  Prognostic significance of CD147 in patients with glioblastoma.

Authors:  Min Yang; Yang Yuan; Hua Zhang; Ming Yan; Shumei Wang; Fuqiang Feng; Peigang Ji; Yi Li; Baofu Li; Guodong Gao; Jipei Zhao; Liang Wang
Journal:  J Neurooncol       Date:  2013-08-08       Impact factor: 4.130

8.  Slug silencing inhibited perineural invasion through regulation of EMMPRIN expression in human salivary adenoid cystic carcinoma.

Authors:  Baolei Wu; Jianhua Wei; Zhiqiang Hu; Chun Shan; Lei Wang; Chenping Zhang; Xi Yang; Xinjie Yang; Delin Lei
Journal:  Tumour Biol       Date:  2015-09-09

9.  CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells.

Authors:  Shi-Jie Wang; Hong-Yong Cui; Yan-Mei Liu; Pu Zhao; Yang Zhang; Zhi-Guang Fu; Zhi-Nan Chen; Jian-Li Jiang
Journal:  Oncotarget       Date:  2015-01-01

10.  New insights into germ cell migration and survival/apoptosis in spermatogenesis: Lessons from CD147.

Authors:  Hao Chen; Kin Lam Fok; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Spermatogenesis       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.